Alterations in integrin expression modulates invasion of pancreatic cancer cells

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Walsh, Naomi ^a   Clynes, Martin ^a   Crown, John ^a,b   O'Donovan, Norma ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; ALPHA6 INTEGRIN; BETA ACTIN; BETA1 INTEGRIN; FIBRONECTIN; MATRIGEL; INTEGRIN; SMALL INTERFERING RNA;

ANCHORAGE INDEPENDENT GROWTH; ANOIKIS; ARTICLE; CANCER INVASION; CELL ADHESION; CELL MOTILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MOLECULAR CLONING; PANCREAS CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL MOTION; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ANOIKIS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION; HUMANS; INTEGRINS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 70350349130     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-140     Document Type: Article

References (37)

1. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078
2. Long-term survival in metastatic pancreatic cancer. A case report and review of the literature. GP Spinelli A Zullo A Romiti M Di Seri F Tomao E Miele B Spalletta A Eramo C Hassan S Tomao, JOP 2006 7 486 491 16998247
3. Cancer statistics, 2007. A Jemal R Siegel E Ward T Murray J Xu MJ Thun, CA Cancer J Clin 2007 57 43 66 10.3322/canjclin.57.1.43 17237035
4. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas. MW Muller H Friess J Koninger D Martin MN Wente U Hinz GO Ceyhan P Blaha J Kleeff MW Buchler, Am J Surg 2008 195 221 228 10.1016/j.amjsurg.2007.02.026 18154768
5. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. JP Neoptolemos JA Dunn DD Stocken J Almond K Link H Beger C Bassi M Falconi P Pederzoli C Dervenis, et al. Lancet 2001 358 1576 1585 10.1016/S0140-6736(01)06651-X 11716884
6. The pathology and genetics of metastatic pancreatic cancer. S Yachida CA Iacobuzio-Donahue, Arch Pathol Lab Med 2009 133 413 422 19260747
7. Integrins: versatility, modulation, and signaling in cell adhesion. RO Hynes, Cell 1992 69 11 25 10.1016/0092-8674(92)90115-S 1555235
8. Multiple roles of integrins in cell motility. SP Holly MK Larson LV Parise, Exp Cell Res 2000 261 69 74 10.1006/excr.2000.5040 11082276
9. The role of integrins in the malignant phenotype of gliomas. JH Uhm CL Gladson JS Rao, Front Biosci 1999 4 188 99 10.2741/Uhm 9989953
10. The alpha 6-integrin receptor in pancreatic carcinoma. RJ Weinel A Rosendahl E Pinschmidt O Kisker B Simon S Santoso, Gastroenterology 1995 108 523 532 10.1016/0016-5085(95)90082-9 7835595
11. Integrin alpha6beta1 role in metastatic behavior of human pancreatic carcinoma cells. R Vogelmann ED Kreuser G Adler MP Lutz, Int J Cancer 1999 80 791 795 10.1002/(SICI)1097-0215(19990301)80:5<791::AID-IJC253.0.CO;2-4 10048983
12. Interleukin-1alpha enhances integrin alpha(6)beta(1) expression and metastatic capability of human pancreatic cancer. H Sawai H Funahashi M Yamamoto Y Okada T Hayakawa M Tanaka H Takeyama T Manabe, Oncology 2003 65 167 173 10.1159/000072343 12931024
13. Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis. R Hosotani M Kawaguchi T Masui T Koshiba J Ida K Fujimoto M Wada R Doi M Imamura, Pancreas 2002 25 30 5 10.1097/00006676-200208000-00021 12142752
14. Low expression of beta 1, alpha 2 and alpha 3 subunits of VLA integrins in malignant mammary tumours. M Pignatelli AM Hanby GW Stamp, J Pathol 1991 165 25 32 10.1002/path.1711650106 1659627
15. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. MM Zutter G Mazoujian SA Santoro, Am J Pathol 1990 137 863 870 2221016
16. Beta1 integrin promotes but is not essential for metastasis of ras-myc transformed fibroblasts. C Brakebusch K Wennerberg HW Krell UH Weidle A Sallmyr S Johansson R Fassler, Oncogene 1999 18 3852 3861 10.1038/sj.onc.1202770 10445848
17. Metastasis results from preexisting variant cells within a malignant tumor. IJ Fidler ML Kripke, Science 1977 197 893 895 10.1126/science.887927 887927
18. Identification of Pancreatic Cancer Stem Cells. C Li DG Heidt P Dalerba CF Burant L Zhang V Adsay M Wicha MF Clarke DM Simeone, Can Res 2007 67 1030 1037 10.1158/0008-5472.CAN-06-2030 (Pubitemid 46270758)
19. Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance. M Heenan L O'Driscoll I Cleary L Connolly M Clynes, Int J Cancer 1998 71 907 915 10.1002/(SICI)1097-0215(19970529)71:5<907::AID-IJC333.0.CO;2-1
20. A rapid in vitro assay for quantitating the invasive potential of tumor cells. A Albini Y Iwamoto HK Kleinman GR Martin SA Aaronson JM Kozlowski RN McEwan, Cancer Res 1987 47 3239 3245 2438036
21. The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. WG Carter EA Wayner TS Bouchard P Kaur, J Cell Biol 1990 110 1387 1404 10.1083/jcb.110.4.1387 1691191
22. Production of autostimulatory growth factors by the human carcinoma line, RPMI 2650. BM Carey M Dooley R Weedle M Clynes, In Vitro Cell Dev Biol 1993 29A 153 160 10.1007/BF02630947 7682548
23. The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. JJ Grzesiak M Bouvet, Br J Cancer 2006 94 1311 1319 10.1038/sj.bjc.6603088 16622460
24. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. EP DiMagno HA Reber MA Tempero, Gastroenterolgy 1999 117 1464 1484 10.1016/S0016-5085(99)70298-2
25. Proteolytic degradation of extracellular matrix in tumor invasion. K Tryggvason M Hoyhtya T Salo, Biochim Biophys Acta 1987 907 191 217 2823896
26. Function of the integrin alpha 6 beta 1 in metastatic breast carcinoma cells assessed by expression of a dominant-negative receptor. LM Shaw C Chao UM Wewer AM Mercurio, Cancer Res 1996 56 959 963 8640785
27. Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule. S Satoh Y Hinoda T Hayashi MD Burdick K Imai MA Hollingsworth, Int J Cancer 2000 88 507 518 10.1002/1097-0215(20001115) 88:4<507::AID-IJC13.0.CO;2-0 11058865
28. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. MS Duxbury H Ito MJ Zinner SW Ashley EE Whang, Surgery 2004 135 555 562 10.1016/j.surg.2003.10.017 15118593
29. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. MS Duxbury H Ito MJ Zinner SW Ashley EE Whang, Oncogene 2004 23 465 473 10.1038/sj.onc.1207036 14724575
30. Strucural and biologic properties of integrin-mediated cell adhesion. DA Cheresh, Clin Lab Med 1992 12 217 236 1611819
31. In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix. GP Gui JR Puddlefoot GP Vinson CA Wells R Carpenter, Br J Surg 1995 82 1192 1196 10.1002/bjs.1800820914 7551993
32. Regulation of expression of fibronectin and its receptor, alpha 5 beta 1, during development and regeneration of peripheral nerve. F Lefcort K Venstrom JA McDonald LF Reichardt, Development 1992 116 767 782 1289065
33. Integrins as receptors for laminins. AM Belkin MA Stepp, Microsc Res Tech 2000 51 280 301 10.1002/1097-0029(20001101)51:3<280::AID-JEMT73.0.CO;2-O 11054877
34. Alpha6beta4 integrin crosslinking induces EGFR clustering and promotes EGF-mediated Rho activation in breast cancer. MZ Gilcrease X Zhou X Lu WA Woodward BE Hall PJ Morrissey, J Exp Clin Can Res 2009 28 67 10.1186/1756-9966-28-67
35. A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor. T Plath K Detjen M Welzel Z von Marschall D Murphy M Schirner B Wiedenmann S Rosewicz, J Cell Biol 2000 150 1467 1478 10.1083/jcb.150.6.1467 10995450
36. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. MJ Reginato KR Mills JK Paulus DK Lynch DC Sgroi J Debnath SK Muthuswamy JS Brugge, Nat Cell Biol 2003 5 733 740 10.1038/ncb1026 12844146
37. Rapid onset of apoptosis in vitro follows disruption of beta 1-integrin/matrix interactions in human colonic crypt cells. J Strater U Wedding TF Barth K Koretz C Elsing P Moller, Gastroenterology 1996 110 1776 1784 10.1053/gast.1996.v110.pm8964403 8964403